Chinese biotechs are trying to move beyond generic medicines and develop new drugs, under the leadership of researchers that have left Big Pharma to return to their native country.
via WSJ.com: US Business http://ift.tt/1xFwQu2
via WSJ.com: US Business http://ift.tt/1xFwQu2
Nessun commento:
Posta un commento